Given the key role of ULK1 in autophagy initiation and the fact that numerous cancer cells depend on autophagy for survival, inhibition of ULK1 with small-molecule inhibitors makes it a promising target for cancer drug discovery (21, 22, 23). Here, ULK1 is linked to cancer.